Press release
Pegfilgrastim Biosimilars Market Report: By Type, Drivers, Industry Analysis, Segments, Top Companies And Forecast To 2032
Pegfilgrastim Biosimilars Market
As per the pegfilgrastim biosimilars market report by The Business Research Company, Government initiatives for the development of biosimilars are expected to drive the pegfilgrastim biosimilars market. Governments worldwide are focusing on the development of biosimilars due to their cost-effective nature. The US Food and Drug Administration (FDA) launched a Biosimilar Action Plan,
The global pegfilgrastim biosimilars market grew from $1.28 billion in 2022 to $1.41 billion in 2023 at a compound annual growth rate (CAGR) of 10.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The pegfilgrastim biosimilars market is expected to grow from $2.04 billion in 2027 at a CAGR of 9.7%.
Read More On The Pegfilgrastim Biosimilars Market Report Here:
https://www.thebusinessresearchcompany.com/report/pegfilgrastim-biosimilar-global-market-report
Major competitors in the pegfilgrastim biosimilars market include Mylan, Biocon, Mundipharma, Pfizer, Sandoz, Coherus, Intas Pharmaceuticals, and Fresenius Kabi
The pegfilgrastim biosimilars market is segmented -
By Application: Chemotherapy Treatment, Transplantation, Other Applications
By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Mail-Order Pharmacies
By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the pegfilgrastim biosimilars market.
Check Out Buying Options For The Pegfilgrastim Biosimilars Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=4015
Pegfilgrastim biosimilars refer to a biosimilar that is intended to be used in conjunction with supportive care for people with non-myeloid cancer. It can help prevent or treat infections brought on by myelosuppressive chemotherapy by promoting the formation of certain white blood cells.
The Table Of Content For The Pegfilgrastim biosimilars market Include:
1. Executive Summary
2. Pegfilgrastim Biosimilars Market Characteristics
3. Pegfilgrastim Biosimilars Market Trends And Strategies
4. Pegfilgrastim Biosimilars Market - Macro Economic Scenario
5. Pegfilgrastim Biosimilars Market Size And Growth
......
27. Pegfilgrastim Biosimilars Market Competitive Landscape And Company Profiles
28. Pegfilgrastim Biosimilars Pipeline Analysis
29. Key Mergers And Acquisitions In The Pegfilgrastim Biosimilars Market
30. Pegfilgrastim Biosimilars Market Future Outlook and Potential Analysis
31. Appendix
The "Global Pegfilgrastim biosimilars market Report 2023" from The Business Research Company is a comprehensive report that covers every facet of a market covering over 60 geographies and over 2500 market segments. The regional and country breakdowns section analyzes the market in each geography and the market size by region and country. Furthermore, it assesses the market's historical and projected growth and identifies significant trends and strategies that companies can leverage for business expansion.
Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx
Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.
Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pegfilgrastim Biosimilars Market Report: By Type, Drivers, Industry Analysis, Segments, Top Companies And Forecast To 2032 here
News-ID: 2876425 • Views: …
More Releases from The Business research company
Offshore Patrol Vessel Global Market Insights: Growth Drivers, Size & Forecasts …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What Is the Forecasted Market Growth Rate of the Offshore Patrol Vessel Industry?
The market size of offshore patrol vessels has seen robust growth in the recent past. The sector, which is projected to be valued at $25.67 billion in 2024, will increase to $27.5 billion in 2025, exhibiting a compound…
Military Exoskeleton Industry Growth Outlook: 12.7% CAGR and $2 Billion by 2029
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
What Is the Long-Term Growth Forecast for the Military Exoskeleton Market Size 2025?
The size of the military exoskeleton market has seen swift growth in the past few years. It is projected to expand from $1.09 billion in 2024 to $1.24 billion in 2025, with a compound annual growth rate (CAGR) of…
Instrument Landing System And Visual Landing Aids Market to Grow at 5.6% CAGR, R …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Instrument Landing System And Visual Landing Aids Market Outlook: How is the Market Expected to Grow by 2025?
Recent years have seen a substantial growth in the size of the instrument landing system and visual landing aids market. Currently valued at $2.27 billion in 2024, it is projected to rise…
Future of Coherent Radar Market: Size, Share & Forecasts to 2029
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What Is the Projected Market Size Valuation of the Coherent Radar Market by 2025?
There has been a significant expansion in the coherent radar market size in the past few years. The market is set to escalate from a worth of $8.18 billion in 2024 to a higher value of $8.92…
More Releases for Pegfilgrastim
Global Neulasta (Pegfilgrastim) And Biosimilar Market Size by Application, Type, …
USA, New Jersey- According to Market Research Intellect, the global Neulasta (Pegfilgrastim) And Biosimilar market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period.
The market for pegfilgrastim and biosimilars is expanding significantly, mostly due to the rising use of chemotherapy-based cancer treatments. By promoting the formation…
Global Pegfilgrastim Market Expects 5.8% Growth Rate from 2021-2028 Amid Rising …
According to the latest report published by Dataintelo, the Global Pegfilgrastim Market is projected to expand at a compound annual growth rate (𝐂𝐀𝐆𝐑) of 5.8% during the period between 2021 and 2028. This significant expansion in the market is primarily driven by the escalating number of cancer cases worldwide and an intensified demand for pegfilgrastim biosimilars.
The report highlights that the evolving global scenario of cancer management and treatment is fostering…
Pegfilgrastim Biosimilars Market Insights, Overview, Share And Forecast To 2033
The pegfilgrastim biosimilars market size has grown rapidly in recent years. It will grow from $1.59 billion in 2023 to $1.75 billion in 2024 at a compound annual growth rate (CAGR) of 10.0%. The growth in the historic period can be attributed to increase in cancer prevalence, government initiatives, increased healthcare expenditure, increase in biopharmaceutical r&d expenditure, low cost of biosimilars, and high penetration of the biosimilar drugs.
The…
Pegfilgrastim Biosimilar Market to Exhibit 10% CAGR through 2026
Chemotherapy and/or radiotherapy is used for the treatment of most cancers. However, chemotherapy and radiotherapy have a very common side effect called neutropenia, and pegfilgrastim is required for its treatment. A study conducted on patients who received chemotherapy in 2016-2017 to evaluate the occurrence of chemotherapy-induced febrile neutropenia (CIFN) showed that, out of 200 patients, 9.5% patients developed neutropenia.
Click HERE to Get Synopsis of the Report- https://www.factmr.com/report/1494/pegfilgrastim-biosimilar-market
Neutropenia patients are highly…
Global Pegfilgrastim Market Analysis Report 2019-2024
This report on Global Pegfilgrastim Market details about the market size, market growth rate and global forecast for the next five years i.e. 2024. The report is a complete analysis assessing the pricing trends, market consumption and sales forecasts. This study covers the competitive landscape by profiling the major market players. The vital information of the market is collected through authentic sources and reviewed by industry experts.
Pegfilgrastim is a PEGylated…
Pegfilgrastim Biosimilar Market: Industry Trends and Developments 2018-2028
Biosimilar is a medical product that is almost an identical copy of an existing drug manufactured by a different company. They require independent approval through clinical trials. The Biosimilar market is an expanding market. Approximately 30% of drugs sold globally are biopharma drugs. 40% of prescription drug spending in the US is on biologic drugs. Filgrastim is used as a medication for treating low levels of blood neutrophils caused by…
